After graduating cum laude in Pharmacy, Alice Melocchi was selected for a Ph.D., during which spent 9 months at Massachusetts Institute of Technology as a visiting student, working within the Novartis-MIT Center for Continuous Manufacturing. In 2015, she earned her Ph.D. from Università degli Studi di Milano and currently she is a researcher at the Department of Pharmaceutical Sciences of the same University. In 2016 Alice co-founded with Federico Parietti the startup Mutilply Labs in which she holds the position of CSO besides her academic roles. The company was selected for taking part in the 2016 summer batch of Y Combinator and aims at the fabrication of personalized drug products thanks to the use of robotics. After a successful seed round, Multiply Labs have recently closed the Series A, also creating a consortium with Cytiva and UCSF focused on the automation of cell-therapy manufacturing. In December 2018, Alice was also nominated among the Inspiring 50 Italy, the most inspiring Italian women in technology.